- Home
- BKD vs NVCR Comparison
BKD vs NVCR Comparison
Compare BKD & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKD
- NVCR
- Stock Information
- Founded
- BKD 2005
- NVCR 2000
- Country
- BKD United States
- NVCR Switzerland
- Employees
- BKD N/A
- NVCR N/A
- Industry
- BKD Hospital/Nursing Management
- NVCR Medical/Dental Instruments
- Sector
- BKD Health Care
- NVCR Health Care
- Exchange
- BKD Nasdaq
- NVCR Nasdaq
- Market Cap
- BKD 1.6B
- NVCR 1.4B
- IPO Year
- BKD 2005
- NVCR 2015
- Fundamental
- Price
- BKD $7.51
- NVCR $12.04
- Analyst Decision
- BKD Buy
- NVCR Buy
- Analyst Count
- BKD 5
- NVCR 7
- Target Price
- BKD $7.70
- NVCR $28.79
- AVG Volume (30 Days)
- BKD 3.2M
- NVCR 1.5M
- Earning Date
- BKD 08-06-2025
- NVCR 07-24-2025
- Dividend Yield
- BKD N/A
- NVCR N/A
- EPS Growth
- BKD N/A
- NVCR N/A
- EPS
- BKD N/A
- NVCR N/A
- Revenue
- BKD $3,015,786,000.00
- NVCR $630,160,000.00
- Revenue This Year
- BKD $8.40
- NVCR $5.44
- Revenue Next Year
- BKD N/A
- NVCR $9.05
- P/E Ratio
- BKD N/A
- NVCR N/A
- Revenue Growth
- BKD 4.14
- NVCR 14.58
- 52 Week Low
- BKD $4.45
- NVCR $11.57
- 52 Week High
- BKD $8.08
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- BKD 55.51
- NVCR 22.71
- Support Level
- BKD $6.65
- NVCR $15.90
- Resistance Level
- BKD $7.90
- NVCR $16.70
- Average True Range (ATR)
- BKD 0.27
- NVCR 0.89
- MACD
- BKD -0.03
- NVCR -0.50
- Stochastic Oscillator
- BKD 62.41
- NVCR 6.63
About BKD Brookdale Senior Living Inc.
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.